Combination use of anti-TROP-2 antibody-conjugated drugs and other therapeutic agents

The invention relates to an application of a combination of an anti-TROP-2 antibody coupling drug and an anti-PD-L1 antibody or other chemotherapeutic drugs such as carboplatin or cis-platinum and the like in preparation of drugs for preventing and/or treating tumor diseases, and the anti-TROP-2 ant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WANG SUXIA, LIU GESHA, YIN WENGUO, DIAO YINA, GUO QI, PAN YANG, WEI YUJUN, GE JUNYOU, JIN XIAOPING, LU LIAN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to an application of a combination of an anti-TROP-2 antibody coupling drug and an anti-PD-L1 antibody or other chemotherapeutic drugs such as carboplatin or cis-platinum and the like in preparation of drugs for preventing and/or treating tumor diseases, and the anti-TROP-2 antibody can be Sacituzumab. 抗TROP-2抗体偶联药物与抗PD-L1抗体或其它化疗药物如卡铂或顺铂等的组合，在制备预防和/或治疗肿瘤疾病药物中的应用，其中抗TROP-2抗体可以是Sacituzumab。